| ActiveSight News (2003-2004) |
 |
| Tuesday, September 18, 2007 |
| ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies Posted 9:11 AM PST |
| |
| Friday, January 5, 2007 |
| ActiveSight Signs Multi-Target Crystallography Service Agreement With Lexicon Pharmaceuticals Posted 9:09 AM PST |
| |
| Tuesday, February 28, 2006 |
| ActiveSight Launches Fragment Screening Service and Four New Crystal Targets for Structure Based Drug Design: FAK, Caspase 3, PTP-1B, and DPP-4 Posted 8:10 AM PST |
| |
| Wednesday, February 22, 2006 |
| QIAGEN and ActiveSight Sign Co-Marketing Agreement Targeting Protein Crystallography Posted 7:37 AM PST |
| |
| Monday, January 23, 2006 |
| ActiveSight Signs Protein Crystallography Agreement With Novo Nordisk Posted 9:17 AM PST |
| |
| Thursday, November 17, 2005 |
| ActiveSight to Provide Crystallography Services to Inpharmatica Posted 8:23 AM PST |
| |
| Tuesday, November 1, 2005 |
| ActiveSight to Provide Protein Crystallography to Ambit Posted 9:02 AM PST |
| |
| Wednesday, April 27, 2005 |
| ActiveSight and Lexicon Pharmaceuticals Sign Second Protein Crystallography Service Agreement Posted 10:35 AM PST |
| |
| Thursday, March 17, 2005 |
| ActiveSight Introduces Protein Crystal Targets for Oncology, Cardiovascular, and Anti-infective Research Posted 9:29 PM PST |
| |
| Wednesday, February 23, 2005 |
| ActiveSight to Provide Protein Crystallography to Serenex Posted 11:51 AM PST |
| |
| Thursday, January 27, 2005 |
| Fructose-1,6-bisphosphatase Diabetes Target Available for Structure Based Drug Design Posted 11:05 AM PST |
| |
